menu
    • menu

    Company profile for Nurix Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nurix Therapeutics discovers drugs that harness the body’s natural process to control protein levels. Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach called targeted protein modulation to treat a broad range of diseases. Our focus is on developing targeted therapies to treat cancer including novel, small molecule immuno-oncology agents...
    Nurix Therapeutics discovers drugs that harness the body’s natural process to control protein levels. Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach called targeted protein modulation to treat a broad range of diseases. Our focus is on developing targeted therapies to treat cancer including novel, small molecule immuno-oncology agents. Nurix was founded by a team of internationally renowned scientific experts in the E3 ubiquitin ligase regulation and structure field

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nurix TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1700 Owens Street, Suite 205 San Francisco, CA 94158
    Telephone
    Telephone
    415-660-5320
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nurixtx.com/contact/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nurix Shows Strong Responses In Phase 1 Bexobrutideg Trial
    Nurix Shows Strong Responses In Phase 1 Bexobrutideg Trial

    06 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/06/3201064/0/en/Nurix-Therapeutics-Presents-New-Data-Demonstrating-Durable-Deepening-Responses-in-Phase-1-Trial-of-Bexobrutideg-NX-5948-in-Patients-with-Relapsed-or-Refractory-Chronic-Lymphocytic-.html

    GLOBENEWSWIRE
    06 Dec 2025
    Share Share
    Nurix Therapeutics To Present Phase 1 Bexobrutideg Data At ASH
    Nurix Therapeutics To Present Phase 1 Bexobrutideg Data At ASH

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196838/0/en/Nurix-Therapeutics-Announces-Webcast-to-Review-New-and-Updated-Data-from-the-Phase-1-Clinical-Trial-of-BTK-Degrader-Bexobrutideg-NX-5948-To-Be-Presented-at-the-67th-American-Societ.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Nurix Therapeutics Joins Piper Sandler Healthcare Conference
    Nurix Therapeutics Joins Piper Sandler Healthcare Conference

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194191/0/en/Nurix-Therapeutics-to-Participate-in-the-Piper-Sandler-37th-Annual-Healthcare-Conference.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Nurix Pharma Reduces Staff After Operational Review
    Nurix Pharma Reduces Staff After Operational Review

    21 Nov 2025

    // BIOSPACE

    https://www.biospace.com/biospace-layoff-tracker

    BIOSPACE
    21 Nov 2025
    Share Share
    Nurix Trims Staff As Trial For Lead BTK Degrader Kicks Off
    Nurix Trims Staff As Trial For Lead BTK Degrader Kicks Off

    21 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/nurix-trims-workforce-pivotal-trial-lead-btk-degrader-kicks

    FIERCE BIOTECH
    21 Nov 2025
    Share Share
    Nurix Therapeutics Appoint Biopharma Leader Roger Dansey to Board
    Nurix Therapeutics Appoint Biopharma Leader Roger Dansey to Board

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184355/0/en/Nurix-Therapeutics-Appoints-Accomplished-Biopharmaceutical-Leader-Roger-Dansey-M-D-to-Its-Board-of-Directors.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search